Mylan's acquisitions

Mylan, a major pharmaceutical company, has expanded by acquiring other companies to broaden its product offerings and increase global reach. Notably, it purchased Abbott's non-U.S. generic division in 2010, gaining access to international markets. In 2015, Mylan acquired the Swedish pharmaceutical firm Meda, boosting its portfolio with over-the-counter and specialty medicines. These acquisitions helped Mylan become a more comprehensive provider of affordable medications worldwide, strengthening its position in the generic drug industry and enabling it to serve more patients efficiently.